Extends the Psychedelic Therapy Advisory Working Group to review research and recommend psychedelic therapies in Vermont.
The bill extends the Psychedelic Therapy Advisory Working Group, tasked with reviewing research on psychedelics' benefits and risks, monitoring other states' programs, and recommending a Vermont pilot project for psilocybin-assisted therapies. The group will submit a report by November 15, 2025, and cease to exist on January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.